mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-07 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |